Article

Screening of tumor antigens and immunogenic cell death landscapes of prostate cancer for exploration of mRNA vaccine

2023-06-30

Abstract excerpt

<h4>Background: </h4> Although the mRNA vaccine is effective against many kinds of cancers, its efficacy against prostate adenocarcinoma (PRAD) is still unclear. In this study, effective antigens of mRNA vaccine were excavated from the perspective of immunogenic cell death (ICD), and ICD subtypes of PRAD were further distinguished to establish an ICD landscape, thereby determining suitable vaccine recipients. Meth...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 54291da8-9a46-5cc8-a8f0-6769737002bb
DOI: 10.21203/rs.3.rs-3102362/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Screening of tumor antigens and immunogenic cell death landscapes of prostate cancer for exploration of mRNA vaccineDOI 10.21203/rs.3.rs-3102362/v1Read

Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccineSemantic proximity Read

Comprehensive analysis of tumor mutation burden and immune microenvironment in prostate cancer.Semantic proximity Read

Screening of novel tumor-associated antigens for lung adenocarcinoma mRNA vaccine development based on pyroptosis phenotype genes.Semantic proximity Read

Establishing a Prognostic Model in Prostate Adenocarcinoma through Comprehensive scRNA-Seq and Bulk RNA-Seq Analysis and ValidationSemantic proximity Read

Identifying novel tumor-related antigens and immune phenotypes for developing mRNA vaccines in lung adenocarcinoma.Semantic proximity Read

Tumor antigens and immunogenic cell death subtypes guided mRNA vaccine development for lower-grade gliomasSemantic proximity Read

Identification of Prostate Cancer Subtypes Based on Immune Signature Scores in Bulk and Single Cell TranscriptomesSemantic proximity Read

Predicting Prostate Adenocarcinoma Patients’ Survival and Immune Signature: A Novel Risk Model Based on Telomere-Related GenesSemantic proximity Read

Identification of tumor antigens and immune subtypes of bladder cancer for mRNA vaccine developmentSemantic proximity Read

Bioinformatics Analysis of GFAP as a Potential Key Regulator in Different Immune Phenotypes of Prostate Cancer.Semantic proximity Read

Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development.Semantic proximity Read

Reversing the "cold" tumor microenvironment: the role of neoantigen vaccines in prostate cancer.Semantic proximity Read